On September 9, Edwards Lifesciences fell 3.49% in regular trading, trading at $86.79 USD/share, with Turnover of $70.61 million.
Within the Health Care Equipment sector where Edwards Lifesciences belongs, the overall sector came under notable pressure. Among individual stocks, Stryker down 7.18%, Boston Scientific down 4.64%, Intuitive Surgical down 4.50%, Abbott Laboratories down 2.13%, Medtronic PLC down 1.38%.
Edwards Lifesciences is a global leader in structural heart disease solutions and critical care monitoring, partnering with leading clinicians and researchers to advance transcatheter heart valve therapies and hemodynamic monitoring systems.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)